Evidence map›Paper›PMID 40007920›Full record

ArticleCureus2025

Unraveling the Enigma: Correlating Thrombus Histopathology With the Number of Passes in Mechanical Thrombectomy.

Namitha K Baby, Joel Sabu, Kevin Jose Madapat, Zulkifli Misri

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Namitha K BabyInternal Medicine, Kasturba Medical College, Mangalore, IND.
Joel SabuInternal Medicine, Father Muller Medical College, Mangalore, IND.
Kevin Jose MadapatClinical Pharmacy, JSS College of Pharmacy, Mysuru, IND.
Zulkifli MisriNeurology, Kasturba Medical College, Mangalore, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Mechanical thrombectomy has revolutionized the treatment of acute ischemic stroke. Although a few studies have explored the correlation between thrombus histopathology and the number of passes required, the relationship remains unclear. The composition of the thrombus significantly influences the complexity of the procedure. Research has shown that erythrocyte-rich clots are associated with better reperfusion outcomes and fewer passes, whereas fibrin-rich clots are more challenging to retrieve and yield poorer outcomes. This study aims to investigate the association between thrombus histopathology and the number of passes during mechanical thrombectomy. Methods This retrospective observational study included 60 patients undergoing mechanical thrombectomy. Thrombus samples were analyzed histologically using hematoxylin-eosin staining and classified as either erythrocyte-rich (>50% erythrocytes) or fibrin-rich (>50% fibrin). The number of thrombectomy passes and patient demographics were recorded. Statistical analysis was performed to identify associations. Results RBC-rich thrombi were associated with fewer passes (p=0.035). Additionally, patients aged 45-65 years had a higher proportion of fibrin-rich clots, which required more passes (p=0.021). Conclusion This study demonstrates a significant association between thrombus histopathology and the number of passes during mechanical thrombectomy. Understanding thrombus composition may aid in tailoring therapeutic approaches and improving patient outcomes. Overall, thrombus composition was significantly correlated with the number of passes, with erythrocyte-rich thrombi requiring fewer attempts for successful retrieval.

Indexed as

clotischemic strokemechanical thrombectomy (mt)number of passesthrombus histopathology

Identifiers

PMID40007920
PMCPMC11851242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.